Exagen Inc. (XGN)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.8900 |
| Open | 1.8900 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.8312 - 1.9332 |
| 52-week range | 1.3000 - 3.4710 |
| Volume | |
| Avg. volume | 45,047 |
| Market cap | 32.662M |
| Beta (5Y monthly) | 1.21 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Exagen Inc (XGN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Margin ...
Exagen Inc (XGN) reports a robust financial performance with significant improvements in revenue, gross margin, and adjusted EBITDA in the first quarter of 2024.
- Simply Wall St.
Exagen First Quarter 2024 Earnings: Beats Expectations
Exagen ( NASDAQ:XGN ) First Quarter 2024 Results Key Financial Results Revenue: US$14.4m (up 28% from 1Q 2023). Net...
- Zacks
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
Exagen (XGN) delivered earnings and revenue surprises of 52.50% and 9.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.